| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/02/2000 | CN1243544A Novel IFN receptor 1 binding proteins, DNA encoding them, and methods of modulating cellular response to interferons |
| 02/02/2000 | CN1243444A Modified tumor necrosis factor |
| 02/02/2000 | CN1243012A Injection of protein invertase sex-gland release substance |
| 02/01/2000 | USRE36547 Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by exogenous and endogenous opioid agonists |
| 02/01/2000 | US6020479 Amino acid transporters and uses |
| 02/01/2000 | US6020478 Human tumor-associated antigen |
| 02/01/2000 | US6020477 DNA sequences coding for the human proteins Tx and Ty related to the interleukin-1β converting enzyme |
| 02/01/2000 | US6020476 DAZ: a gene family associated with azoospermia |
| 02/01/2000 | US6020474 ATP synthase subunits |
| 02/01/2000 | US6020473 Nucleic acids encoding variants of vascular endothelial cell growth factor |
| 02/01/2000 | US6020469 Freeze drying (lyophilization) is considered useful and effective for preservation of many biologically active materials. |
| 02/01/2000 | US6020468 Antibodies directed against binding-associated epitopes |
| 02/01/2000 | US6020467 Antibodies against sulfotransferase |
| 02/01/2000 | US6020466 Myeloid cell leukemia associated gene mcl-1 |
| 02/01/2000 | US6020465 Recombinant avian type i interferon |
| 02/01/2000 | US6020464 Isolated Smad protein |
| 02/01/2000 | US6020463 Compositions and methods for the treatment and diagnosis of cardiovascular disease using rchd523 as a target |
| 02/01/2000 | US6020462 Nucleic acids encoding the hypoxia inducible factor-1 |
| 02/01/2000 | US6020460 Conformationally stabilized cell adhesion peptides |
| 02/01/2000 | US6020356 Pharmaceutical composition for the treatment of autoimmune diseases |
| 02/01/2000 | US6020331 β-sheet mimetics and use thereof as protease inhibitors |
| 02/01/2000 | US6020327 Control of hair growth |
| 02/01/2000 | US6020326 Method for inhibition of bone growth by anionic polymers |
| 02/01/2000 | US6020318 DNA methyltransferase genomic sequences and antisense oligonucleotides |
| 02/01/2000 | US6020314 Methods for treatment of neurological disorders |
| 02/01/2000 | US6020312 Synthetic antibiotics |
| 02/01/2000 | US6020311 GRF analogs with increased biological potency |
| 02/01/2000 | US6020310 Method for assisting in differential diagnosis and treatment of autistic syndromes |
| 02/01/2000 | US6020309 Pharmaceuticals based on papillomaviruses |
| 02/01/2000 | US6020308 Methods for improving therapeutic effectiveness of treatment of vascularization disorders |
| 02/01/2000 | US6020307 Compositions and methods for isolating lung surfactant hydrophobic proteins SP-B and SP-C |
| 02/01/2000 | US6020306 Receptor-type tyrosine kinase and use thereof |
| 02/01/2000 | US6020305 Treatment of stress-induced skin disease by corticotropin releasing hormone antagonists and skin mast cell degranulation inhibitors |
| 02/01/2000 | US6020201 Isolated nucleic acid molecules which encode mammalian or rodent 2,8 polysialyl transferases |
| 02/01/2000 | US6020199 Antisense modulation of PTEN expression |
| 02/01/2000 | US6020193 Recombinant C-proteinase and processes, methods and uses thereof |
| 02/01/2000 | US6020189 Fibroblast growth factor homologous factors (FHFs) and methods of use |
| 02/01/2000 | US6020181 Inhibition of thrombus formation by medical related apparatus comprising treating with fibrinolytic matrix metalloproteinase |
| 02/01/2000 | US6020179 Nucleic acids encoding human tyrosine phosphatases |
| 02/01/2000 | US6020171 Method of preparing plasmid having both expressing ability of retroviral gene and processing ability after translation, and resultant plasmid and expression products thereof |
| 02/01/2000 | US6020170 Method of preparing a monoclonal antibody |
| 02/01/2000 | US6020168 Porcine CNP gene and precursor protein |
| 02/01/2000 | US6020167 Composition used as a therapeutic agent against chronic viral hepatic diseases |
| 02/01/2000 | US6020166 Nucleic acid encoding an altered telomere repeat binding factor 2 |
| 02/01/2000 | US6020165 Cytikine signal regulators |
| 02/01/2000 | US6020164 Human RNA binding proteins |
| 02/01/2000 | US6020163 Lipocalin homolog |
| 02/01/2000 | US6020161 PIGR-1, a member of immunoglobulin gene superfamily |
| 02/01/2000 | US6020160 For the treatment of infection, particularly bacterial infections. |
| 02/01/2000 | US6020159 3-dehydroquinate synthase |
| 02/01/2000 | US6020157 Polynucleotides encoding HFGAN72X receptor |
| 02/01/2000 | US6020155 Nucleic acids encoding CR1 fusion protein, vector, transfected cell and expression |
| 02/01/2000 | US6020154 H. influenzae HxuB and HxuC genes, proteins and methods of use |
| 02/01/2000 | US6020152 Lymphocyte-associated cell surface protein |
| 02/01/2000 | US6020145 Methods for determining the presence of carcinoma using the antigen binding region of monoclonal antibody BR96 |
| 02/01/2000 | US6020144 These organisms have evolved a sophisticated ability to infect a host and evade their host's immune defenses. |
| 02/01/2000 | US6020143 The invention is concerned with the identification, isolation and cloning of genes which are associated with alzheimer's disease. |
| 02/01/2000 | US6020142 Rath genes and polypeptides and methods for the treatment and diagnosis of immune disorders |
| 02/01/2000 | US6020139 S-adenosyl methionine regulation of metabolic pathways and its use in diagnosis and therapy |
| 02/01/2000 | US6020134 Method for diagnosing cancer via DNA hybridization |
| 02/01/2000 | US6020125 For use as antigens, immunogenic compositions, including vaccines, carriers for other antigens and immunogens and the generation of diagnostic reagents. |
| 02/01/2000 | US6020121 Screening for an inhibitor of a global regulator of pathogenesis genes |
| 02/01/2000 | US6019987 Isolated, MAGE-3 derived peptides which complex with HLA-A2 molecules and uses thereof |
| 02/01/2000 | US6019984 Bacterial preparations, method for producing same, and their use as vaccines |
| 02/01/2000 | US6019982 Mutant enterotoxin effective as a non-toxic oral adjuvant |
| 02/01/2000 | US6019979 Anti-viral treatment with pertussis toxin B oligomer |
| 02/01/2000 | US6019972 Peptides of human T cell reactive feline protein (TRFP) |
| 02/01/2000 | US6019971 Treatment of autoimmune arthritis by oral administration of collagen |
| 02/01/2000 | US6019969 Composition comprising antibody to macrophage-derived inflammatory mediator (MIP-α 1 and MIP-1β) |
| 02/01/2000 | US6019968 Dispersible antibody compositions and methods for their preparation and use |
| 02/01/2000 | US6019967 Therapeutic/cosmetic compositions comprising CGRP antagonists for treating sensitive human skin |
| 02/01/2000 | US6019965 Alveolar proteinosis |
| 02/01/2000 | US6019958 Polybasic compound having a molecular weight from about 500 daltons to about 15,000 daltons with a technetium-99m binding moiety covalently linked to the compound; and a polysulfated glycan having a molecular weight of at least about 1,000 |
| 02/01/2000 | CA2173387C A process for the preparation of a liposomal, in water dispersive, orally administerable, solid, dry therapeutic formulation |
| 02/01/2000 | CA2171982C Drug binding protein |
| 02/01/2000 | CA2105492C Glutathione analogs and paralog panels comprising glutathione mimics |
| 02/01/2000 | CA2069085C Activatable fibrinolytic and anti-thrombotic proteins |
| 02/01/2000 | CA2035039C Recombinant poxvirus and streptococcal m protein vaccine |
| 02/01/2000 | CA1340888C Vaccines and diagnostic assays for haemophilus influenzae |
| 01/27/2000 | WO2000004183A1 Bone morphogenic protein |
| 01/27/2000 | WO2000004172A1 Method of making proteins in transformed yeast cells |
| 01/27/2000 | WO2000004171A1 Treatment of diabetes with synthetic beta cells |
| 01/27/2000 | WO2000004169A1 New caspase homologue |
| 01/27/2000 | WO2000004157A2 Cloning and characterisation of novel mammalian peptidases |
| 01/27/2000 | WO2000004153A2 Repression of cell transformation with human pea3 |
| 01/27/2000 | WO2000004150A1 Human presenilin-associated protein |
| 01/27/2000 | WO2000004149A2 Compositions and methods for therapy and diagnosis of prostate cancer |
| 01/27/2000 | WO2000004148A1 Tissue factor protein variants with increased affinity for coagulation factor fvii/fviia |
| 01/27/2000 | WO2000004145A2 Myotilin, an actin-organizing protein |
| 01/27/2000 | WO2000004144A1 Snurpotine i human m3g-cap specific nucleus import receptor protein with new domain structure, the production and use thereof |
| 01/27/2000 | WO2000004142A1 Mucins |
| 01/27/2000 | WO2000004141A2 Use of nucleic acid molecules as antiviral agents |
| 01/27/2000 | WO2000004137A1 Human aspartic proteases |
| 01/27/2000 | WO2000004135A2 Human scad-related molecules, scrm-1 and scrm-2 |
| 01/27/2000 | WO2000004052A2 Soluble derivatives of anti-angiogenic peptides |
| 01/27/2000 | WO2000004051A2 Growth differentiation factor promoter and uses therefor |
| 01/27/2000 | WO2000004050A2 Neurotrophic growth factor |
| 01/27/2000 | WO2000004049A1 Chimeric polypeptides allowing expression of plant-noxious proteins |
| 01/27/2000 | WO2000004048A1 Peptides of il-2 and derivatives thereof and their use as therapeutic agents |
| 01/27/2000 | WO2000004047A1 Cosmetic compositions for slimming |